Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.36 |
| ▸ | CTSG | P08311 | 1/20 | 0.36 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2864488 | 0.82 | ELANE (0.38) | ELANECTSG | |
| SCHEMBL2872294 | 0.76 | ELANE (0.32) | ELANECTSG | |
| SCHEMBL2862454 | 0.74 | KDM4E (0.32) | — | |
| SCHEMBL9188468 | 0.72 | ELANE (0.39) | ELANECTSGDAO | |
| SCHEMBL6704515 | 0.68 | PPARA (0.41) | ELANECTSG | |
| SCHEMBL9842487 | 0.68 | PDCD1 (0.47) | ELANECTSG | |
| SCHEMBL14877332 | 0.67 | TAAR1 (0.46) | DAO | |
| SCHEMBL8674511 | 0.67 | ELANE (0.38) | ELANECTSGDAO | |
| SCHEMBL16284304 | 0.67 | TOP1 (0.49) | ELANECTSGDAO | |
| SCHEMBL8019860 | 0.67 | ELANE (0.36) | ELANECTSGDAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1964860-B1 | ETHYLENE POLYMER, CATALYST FOR PRODUCTION OF ETHYLENE POLYMER, AND PROCESS FOR PRODUCTION OF ETHYLENE POLYMER | TOSOH CORP (JP) | 2017-07-05 | — | — | EP | disclosed |
| EP-1473323-B1 | Polyethylene composition and process for producing same | TOSOH CORP (JP) | 2016-04-27 | — | — | EP | disclosed |
| US-7838611-B2 | Ethylene polymer, catalyst for ethylene polymer production, and method for producing ethylene polymer | TOSOH CORPORATION (JP) | 2010-11-23 | — | — | US | disclosed |
| US-7678866-B2 | Polyethylene composition and process for producing same | TOSOH CORPORATION (JP) | 2010-03-16 | — | — | US | disclosed |
| US-20090137755-A1 | ETHYLENE POLYMER, CATALYST FOR ETHYLENE POLYMER PRODUCTION, AND METHOD FOR PRODUCING ETHYLENE POLYMER | TOSOH CORPORATION (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-1964860-A1 | ETHYLENE POLYMER, CATALYST FOR PRODUCTION OF ETHYLENE POLYMER, AND PROCESS FOR PRODUCTION OF ETHYLENE POLYMER | Tosoh Corporation (JP) | 2008-09-03 | — | — | EP | disclosed |
| US-7166684-B2 | Transition metal compound, catalyst for olefin polymerization and method for producing polyolefin | JAPAN POLYETHYLENE CORPORATION (JP) | 2007-01-23 | — | — | US | disclosed |
| US-20060167196-A1 | Novel transition metal compound, catalyst for olefin polymerization and method for producing polyolefin | JAPAN POLYETHYLENE CORPORATION (JP) | 2006-07-27 | — | — | US | disclosed |
| EP-1473323-A1 | Polyethylene composition and process for producing same | Tosoh Corporation (JP) | 2004-11-03 | — | — | EP | disclosed |
| US-20040214953-A1 | Polyethylene composition and process for producing same | TOSOH CORPORATION | 2004-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060167196-A1 | Novel transition metal compound, catalyst for olefin polymerization and method for producing polyolefin | PCLAF, ZKSCAN2, POF1B | ELANE 3898/4885CTSG 3414/4885DAO 3513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.